Natalie Matosin
TitleCited byYear
Negativity towards negative results: a discussion of the disconnect between scientific worth and scientific culture
N Matosin, E Frank, M Engel, JS Lum, KA Newell
Disease models & mechanisms 7 (2), 171-173, 2014
Metabotropic glutamate receptor 5 in the pathology and treatment of schizophrenia
N Matosin, KA Newell
Neuroscience & Biobehavioral Reviews 37 (3), 256-268, 2013
Metabotropic glutamate receptor mGluR2/3 and mGluR5 binding in the anterior cingulate cortex in psychotic and nonpsychotic depression, bipolar disorder and schizophrenia …
N Matosin, F Fernandez-Enright, E Frank, C Deng, J Wong, XF Huang, ...
Journal of psychiatry & neuroscience: JPN 39 (6), 407, 2014
Understanding the molecular mechanisms underpinning gene by environment interactions in psychiatric disorders: the FKBP5 model
N Matosin, T Halldorsdottir, EB Binder
Biological psychiatry 83 (10), 821-830, 2018
Metabotropic glutamate receptor 5 binding and protein expression in schizophrenia and following antipsychotic drug treatment
N Matosin, E Frank, C Deng, XF Huang, KA Newell
Schizophrenia research 146 (1-3), 170-176, 2013
Homer1/mGluR5 activity moderates vulnerability to chronic social stress
KV Wagner, J Hartmann, C Labermaier, AS Häusl, G Zhao, D Harbich, ...
Neuropsychopharmacology 40 (5), 1222, 2015
Molecular evidence of synaptic pathology in the CA1 region in schizophrenia
N Matosin, F Fernandez-Enright, JS Lum, M Engel, JL Andrews, ...
npj Schizophrenia 2, 16022, 2016
Preclinical and clinical evidence of DNA methylation changes in response to trauma and chronic stress
N Matosin, C Cruceanu, EB Binder
Chronic stress 1, 2470547017710764, 2017
Alterations of mGluR5 and its endogenous regulators Norbin, Tamalin and Preso1 in schizophrenia: towards a model of mGluR5 dysregulation
N Matosin, F Fernandez-Enright, SJ Fung, JS Lum, M Engel, JL Andrews, ...
Acta neuropathologica 130 (1), 119-129, 2015
Rethinking metabotropic glutamate receptor 5 pathological findings in psychiatric disorders: implications for the future of novel therapeutics
KA Newell, N Matosin
BMC psychiatry 14 (1), 23, 2014
Shifting towards a model of mGluR5 dysregulation in schizophrenia: consequences for future schizophrenia treatment
N Matosin, F Fernandez-Enright, JS Lum, KA Newell
Neuropharmacology 115, 73-91, 2017
Metabotropic glutamate receptor 5, and its trafficking molecules Norbin and Tamalin, are increased in the CA1 hippocampal region of subjects with schizophrenia
N Matosin, F Fernandez-Enright, JS Lum, JL Andrews, M Engel, ...
Schizophrenia research 166 (1-3), 212-218, 2015
Neurodevelopmental expression profile of dimeric and monomeric group 1 mGluRs: relevance to schizophrenia pathogenesis and treatment
JS Lum, F Fernandez, N Matosin, JL Andrews, XF Huang, L Ooi, ...
Scientific reports 6, 34391, 2016
Interactions of early-life stress with the genome and epigenome: from prenatal stress to psychiatric disorders
C Cruceanu, N Matosin, EB Binder
Current Opinion in Behavioral Sciences 14, 167-171, 2017
Alterations of ubiquitin related proteins in the pathology and development of schizophrenia: Evidence from human and animal studies
JL Andrews, FJ Goodfellow, N Matosin, MK Snelling, KA Newell, ...
Journal of psychiatric research 90, 31-39, 2017
Alterations of p75 neurotrophin receptor and Myelin transcription factor 1 in the hippocampus of perinatal phencyclidine treated rats
JL Andrews, KA Newell, N Matosin, XF Huang, F Fernandez-Enright
Progress in Neuro-Psychopharmacology and Biological Psychiatry 63, 91-97, 2015
NMDA receptor antagonism by phencyclidine reduces NWASP and WAVE1 protein expression and reduces levels of myelination markers in the prefrontal cortex of rats
JL Andrews, KA Newell, N Matosin, XF Huang, F Fernandez-Enright
Metabotropic glutamate receptor in the pathophysiology and treatment of schizophrenia and major depression
KA Newell, N Matosin, JS Lum
Effects of common GRM5 genetic variants on cognition, hippocampal volume and mGluR5 protein levels in schizophrenia
N Matosin, KA Newell, Y Quidé, JL Andrews, N Teroganova, MJ Green, ...
Brain imaging and behavior 12 (2), 509-517, 2018
mGluR2/3 agonist LY379268 rescues NMDA and GABAA receptor level deficits induced in a two-hit mouse model of schizophrenia
M Engel, P Snikeris, N Matosin, KA Newell, XF Huang, E Frank
Psychopharmacology 233 (8), 1349-1359, 2016
The system can't perform the operation now. Try again later.
Articles 1–20